β³ Fetching live dividend data...
Home βΊ Calculator βΊ LEGN Dividend Calculator 2026
Legend Biotech Corporation Β· NASDAQ
Price: $27.87 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in LEGN β $10.99M in 10 years Β· $64.19/month
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open LEGN position with:
Real after-tax yield depends on where you live and how you hold LEGN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 7.18% | 4.38% | $718 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 6.10% | 3.30% | $610 / yr |
| πΊπΈ US Taxable (20%) | 20% | 5.74% | 2.94% | $574 / yr |
| π¬π§ UK ISA | 0% | 7.18% | 4.38% | $718 / yr |
| π¬π§ UK Taxable | 8.75% | 6.55% | 3.75% | $655 / yr |
| π¨π¦ TFSA | 0% | 7.18% | 4.38% | $718 / yr |
| π¨π¦ CA Taxable | 25% | 5.38% | 2.58% | $539 / yr |
| π¦πΊ Super (pension) | 15% | 6.10% | 3.30% | $610 / yr |
| π¦πΊ AU Taxable | 30% | 5.03% | 2.23% | $503 / yr |
| π©πͺ DE Taxable | 26.375% | 5.29% | 2.49% | $529 / yr |
| π«π· FR Taxable | 30% | 5.03% | 2.23% | $503 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
LEGN pays quarterly β 4 times per year. Next ex-div: TBD.
How LEGN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LEGN sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-06-30 | 6,000 | $14.80 | $88.8K | ||
| G-Gift | 2026-06-30 | 3,382 | β | β | ||
| Sale | 2026-06-25 | 5,566 | $14.78 | $82.3K | ||
| Sale | 2026-03-25 | 9,936 | $8.77 | $87.1K | ||
| Other | 2026-03-18 | 30,000 | $23.27 | $698.1K | ||
| Other | 2026-03-18 | 30,000 | $14.12 | $423.6K | ||
| Other | 2026-03-18 | 30,000 | $23.27 | $698.1K | ||
| Other | 2026-03-18 | 30,000 | $11.50 | $345.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LEGN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Legend Biotech Corporation (LEGN) is currently trading at $27.87, 63% below its 52-week high. The current dividend yield is 7.18% based on an annual payout of $2.00 per share.
Legend Biotech Corporation (LEGN) is a healthcare stock currently trading at $27.87 with a dividend yield of 7.18%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β